MedShape, Inc. has officially secured a groundbreaking patent for their “All-suture anchor, instruments, and methods of using the same” under US Patent Number 12,672,867. As a pioneering medical device company based in Atlanta, they are constantly pushing the boundaries of orthopedic surgery.
This newly patented assembly utilizes an elongated, flexible sleeve combined with an intricate deployment strand system. By routing the free ends of the deployment strands through looped ends to form a loose square knot, surgeons can apply tension to seamlessly compress the sleeve into a tightened anchor configuration. This mechanism securely fixes soft tissues to bone while entirely bypassing the need for traditional, bulky metallic or hard plastic implants.
Why This Invention is Innovative
The fundamental brilliance of this device lies in its exclusive reliance on suture mechanics and a dynamic sleeve. Traditional bone anchors often require drilling large bone tunnels and leaving rigid materials behind, which can lead to complications such as implant migration, bone loss, and interference with post-operative MRI imaging. MedShape’s all-suture anchor addresses these issues by using a flexible construct that morphs into a hardened anchor point only when tensioned. This allows for a much smaller surgical footprint, minimizes bone removal, and ultimately preserves the patient’s native anatomy while delivering exceptional pullout strength.
Winner of the Georgia State Patent of the Month for August 2026
Due to its profound impact on surgical science, this all-suture technology was proudly awarded the Georgia State Patent of the Month for August 2026. The state of Georgia is home to a rapidly expanding bioscience and biomedical engineering sector. The state innovation board recognized MedShape, Inc. for embodying this spirit of excellence. The award highlighted the patent’s capacity to drastically improve patient recovery times and commended the exceptional engineering ingenuity developed right in the heart of Atlanta. Recognizing this technology underscores the region’s commitment to supporting local enterprises that provide massive global healthcare solutions.
R&D Tax Credit Eligibility in the USA
The practical applications and developmental lifecycle of this patent are prime examples of activities eligible for the Research and Development (R&D) Tax Credit under Section 41 of the US tax code. Developing this all-suture anchor required resolving significant technological uncertainties surrounding biomechanics, material science, and surgical deployment. The engineering team at MedShape had to undergo a rigorous process of systematic experimentation. This included creating iterative prototypes, conducting tensile and cyclical load testing on various knot configurations, and refining the deployment instrumentation to ensure fail proof tightening under physiological stress. The financial investments made into these testing protocols, labor, and specialized supplies represent qualified research expenses. By claiming the R&D tax credit, companies in the medical device sector can recoup a meaningful portion of their developmental costs to fuel ongoing clinical innovation.
